Cognilum is a wearable transcranial photobiomodulation (tPBM) device under investigation for the reduction of symptoms of moderate to severe autism spectrum disorder (ASD) in pediatric patients aged 2 to 6 years.
If you have a Hayes login, click here to view the full report on the Knowledge Center.